Par Drugs & Chemicals Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is -33.16% vs 2.37% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is -82.29% vs 16.22% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -76.24% vs -0.16% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is 300.00% vs -80.00% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Par Drugs & Che. With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

19.61

30.74

-11.13

-36.21%

Other Operating Income

0.00

Total Operating income

19.61

30.74

-11.13

-36.21%

Raw Material Cost

8.85

26.92

-18.07

-67.12%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.06

-1.27

1.33

104.72%

Employee Cost

1.94

1.41

0.53

37.59%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

7.32

2.42

4.90

202.48%

Total Expenditure (Excl Depreciation)

18.17

29.48

-11.31

-38.36%

Operating Profit (PBDIT) excl Other Income

1.44

1.26

0.18

14.29%

Other Income

0.36

2.85

-2.49

-87.37%

Operating Profit (PBDIT)

1.80

4.11

-2.31

-56.20%

Interest

0.04

0.56

-0.52

-92.86%

Exceptional Items

0.00

Gross Profit (PBDT)

1.76

3.55

-1.79

-50.42%

Depreciation

0.93

0.72

0.21

29.17%

Profit Before Tax

0.83

2.82

-1.99

-70.57%

Tax

-0.02

0.38

-0.40

-105.26%

Provisions and contingencies

0.00

Profit After Tax

0.85

2.44

-1.59

-65.16%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

0.85

2.44

-1.59

-65.16%

Equity Capital

12.30

23.95

-11.65

-48.64%

Face Value

10.00

0.00

Reserves

99.68

0.00

99.68

Earnings per share (EPS)

0.69

1.02

-0.33

-32.35%

Diluted Earnings per share

0.69

1.02

-0.33

-32.35%

Operating Profit Margin (Excl OI)

7.34%

4.10%

0.00

3.24%

Gross Profit Margin

8.98%

11.55%

0.00

-2.57%

PAT Margin

4.33%

7.94%

0.00

-3.61%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 19.61 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -33.16% vs 2.37% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -12.18% vs -2.15% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 0.85 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -82.29% vs 16.22% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -48.48% vs -55.65% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 1.44 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -76.24% vs -0.16% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -40.74% vs -60.10% in Mar 2025

Quarterly - Interest

Interest 0.04 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 300.00% vs -80.00% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 100.00% vs -60.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 7.34%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025